Commit To Buy Pacira Pharmaceuticals At $35, Earn 9.7% Annualized Using Options
October 04, 2018 at 11:49 AM EDT
Investors considering a purchase of Pacira Pharmaceuticals Inc. (PCRX) shares, but cautious about paying the going market price of $45.50/share, might benefit from considering selling puts among the alternative strategies at their disposal..